TOP1 higher expression was shown to be associated with breast cancer, where it is a predictor of poor prognosis [43], but its role in colon cancer has not been established Antibody neutralization of TNFRSF6B in hepatocellular carcinoma cell lines inhibited proliferation and induced apoptosis [44]. Here, TOP1 is linked to breast carcinoma.